601 - 610 of 7942 Results
Title
Year
- Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications2023OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://doi.org/10.7554/elife.91645Citation Count: 21
-
OPENTitle: Patients with progressive supranuclear palsy need to be seen sooner and more frequentlyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105883End Page: 105883Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105883Citation Count: 1
- Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project2023RESTRICTEDTitle: Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease ProjectJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 10Start Page: e0292180End Page: e0292180Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0292180Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292180&type=printableCitation Count: 0
- Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease2023RESTRICTEDTitle: Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 115Issue #:Start Page: 105822End Page: 105822Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105822Citation Count: 0
-
RESTRICTEDTitle: Development of a highly potent and selective degrader of LRRK2Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 94Issue #:Start Page: 129449End Page: 129449Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2023.129449Citation Count: 8
- Exploratory correlation of the human structural connectome with non‐MRI variables in Alzheimer's disease2023OPENTitle: Exploratory correlation of the human structural connectome with non‐MRI variables in Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/dad2.12511Citation Count: 3
- Mental health disparities and the role of perceived discrimination among Latinx individuals living with Parkinson's disease2023OPENTitle: Mental health disparities and the role of perceived discrimination among Latinx individuals living with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 116Issue #:Start Page: 105867End Page: 105867Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105867Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105867Citation Count: 2
- Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neurons2023OPENTitle: Parallel neurodegenerative phenotypes in sporadic Parkinson’s disease fibroblasts and midbrain dopamine neuronsJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 229Issue #:Start Page: 102501End Page: 102501Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102501Best OA location URL: https://doi.org/10.1016/j.pneurobio.2023.102501Citation Count: 4
- Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neurons2023OPENTitle: Simulations predict differing phase responses to excitation vs. inhibition in theta-resonant pyramidal neuronsJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 130Issue #: 4Start Page: 910End Page: 924Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1152/jn.00160.2023Best OA location URL: https://doi.org/10.1152/jn.00160.2023Citation Count: 1
-
RESTRICTEDTitle: Targeting LRRK2 mRNA stability in Parkinson’s diseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 47Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tins.2023.10.003Citation Count: 1